Skip to content

Clinical trials

Non-alcoholic Fatty Liver Disease trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Country / region: Belgium Clear all

58 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20122
20141
20153
20163
20178
20182
20197
20209
20217
20225
20234
20244
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Terminated14
Recruiting8
Active, not recruiting6
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ziekenhuis Oost-Limburg6
Boehringer Ingelheim3
Gilead Sciences3
Inventiva Pharma3
Novartis Pharmaceuticals3
Novo Nordisk A/S3
Pfizer3
Tobira Therapeutics, Inc.3
89bio, Inc.2
Eli Lilly and Company2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease58
Fatty Liver8
Fibrosis8
Liver Diseases8
Liver Cirrhosis6
Digestive System Diseases5
Diabetes Mellitus, Type 24
Metabolic Diseases3
Cardiovascular Diseases2
Diabetes Mellitus, Type 12

Trials

Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.